Early research (Phase 1)Study completedNCT01596673What this trial is testingAssess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid UsersWho this might be right forDrug Abuse Cephalon 100
Post-approval studies (Phase 4)Study completedNCT06247488What this trial is testingAbuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid UsersWho this might be right forAbuse Potential Arbor Pharmaceuticals, Inc. 110
Early research (Phase 1)Study completedNCT06453265What this trial is testingAssess the Abuse Potential of Intranasal CebranopadolWho this might be right forAbuse, Drug Tris Pharma, Inc. 48
Early research (Phase 1)Study completedNCT01380093What this trial is testingAbuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid UsersWho this might be right forNondependent Opioid Abuse, Episodic Pfizer 80
Early research (Phase 1)Study completedNCT05256108What this trial is testingAssessment of Abuse Potential of Cebranopadol in HumansWho this might be right forHuman Abuse Potential Tris Pharma, Inc. 38
Early research (Phase 1)Study completedNCT03475862What this trial is testingNasal Human Abuse Potential of PTI-821Who this might be right forOpioid Abuse Nondependent Pain Therapeutics 38
Early research (Phase 1)Study completedNCT01746901What this trial is testingCharacterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid AbusersWho this might be right forHealthy Pfizer 81